v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (4,738) $ (12,831)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 8,370 14,627
Depreciation and amortization 2,878 2,976
Provision for bad debts 340 298
Deferred income taxes (875) (4,607)
Non-cash lease expense 474 1,047
Amortization and accretion of marketable securities (1,130) (2,256)
Other 780 725
Change in operating assets and liabilities:    
Accounts receivable 1,442 (1,653)
Prepaid expenses and other assets (111) 72
Deferred commissions 335 537
Other assets 737 435
Accounts payable (733) (1,718)
Accrued expenses and other liabilities (4,684) (148)
Accrued interest (6,843) (6,881)
Deferred revenue 870 891
Operating lease liabilities (597) (1,428)
Net cash used in operating activities (3,485) (9,914)
Cash flows from investing activities    
Purchases of property and equipment (140) (295)
Capitalized internal-use software costs (2,063) (2,619)
Purchases of marketable securities (62,905) (146,657)
Sales of marketable securities 1,301 983
Paydowns, maturities, and redemptions of marketable securities 140,538 187,642
Net cash provided by investing activities 76,731 39,054
Cash flows from financing activities    
Repurchase of common stock (9,533) (27,475)
Proceeds from exercise of stock options 301 1,516
Payments of tax withholdings on net settlement of equity awards (1,066) (2,201)
Proceeds from issuance of stock under employee stock purchase plan 0 1,665
Net cash used in financing activities (10,298) (26,495)
Net increase in cash and cash equivalents 62,948 2,645
Beginning of period 188,028 218,432
End of period $ 250,976 $ 221,077